In contrast, Gelfand found 4.7% (15/318) of MS patients suffered from MME [39].The lower incidence of MME in this study could be explained by the fact that AQP4-Ab-positive ON will undergo a long-term course of disease to progress to definite NMO. The gene discussed is AQP4; the disease is myeloid sarcoma.